SEC Form 4 · accession 0001209191-17-036939
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
May 30, 2017
Accepted (ET)
Jun 1, 2017 · 7:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 30, 2017 | M | 10,000 | $2.90 | A | 169,326 | D | |
| Common StockF2 | Jun 1, 2017 | F | 1,918 | $27.60 | D | 167,408 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $2.90 | May 30, 2017 | M | 10,000 | D | — | Jun 24, 2020 | Common Stock | 10,000 | 4,357 | D |
Explanation of responses
- F1Includes 1,421 shares purchased through the issuer's employee stock purchase plan on May 15, 2017.
- F2Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- F3Fully vested.